Disclosed positions

Estimated from their latest filings — positions may have changed since

$8.55M

combined est. value

Stock	Shares	Price	Value	Weight	As of
TSHATaysha Gene Therapies, Inc.	1,317,389	$6.49	$8.55M	100%	2026-01-26

TSHA

Taysha Gene Therapies, Inc.

$8.55M

1,317,389 sh

All filings on record

Every Form 4 transaction we track for this filer

all 14buys 0sells 7

Stock	Transaction	Date	~6mo later
TSHATaysha Gene Therapies, Inc.	Sell $124.1K · 26,918 sh	2026-01-26	—
TSHATaysha Gene Therapies, Inc.	Sell $423.4K · 89,132 sh	2026-01-23	—
TSHATaysha Gene Therapies, Inc.	Grant — · 427,000 sh	2026-01-12	—
TSHATaysha Gene Therapies, Inc.	Sell $942.0K · 200,000 sh	2026-01-12	—
TSHATaysha Gene Therapies, Inc.	Exercise $151.6K · 88,676 sh	2026-01-12	—
TSHATaysha Gene Therapies, Inc.	Exercise $77.8K · 111,324 sh	2026-01-12	—
TSHATaysha Gene Therapies, Inc.	Sell $1.17M · 260,047 sh	2025-12-01	—
TSHATaysha Gene Therapies, Inc.	Exercise $444.7K · 260,047 sh	2025-12-01	—
TSHATaysha Gene Therapies, Inc.	Sell $523.1K · 110,125 sh	2025-11-28	—
TSHATaysha Gene Therapies, Inc.	Exercise $68.3K · 39,953 sh	2025-11-28	—
TSHATaysha Gene Therapies, Inc.	Exercise $49.0K · 70,172 sh	2025-11-28	—
TSHATaysha Gene Therapies, Inc.	Sell $646.0K · 200,000 sh	2025-09-10	—
TSHATaysha Gene Therapies, Inc.	Exercise $28.8K · 41,150 sh	2025-09-10	—
TSHATaysha Gene Therapies, Inc.	Sell $162.6K · 57,054 sh	2025-08-21	—

TSHASell

2026-01-26 · Taysha Gene Therapies, Inc.

$124.1K

—

TSHASell

2026-01-23 · Taysha Gene Therapies, Inc.

$423.4K

—

TSHAGrant

2026-01-12 · Taysha Gene Therapies, Inc.

427,000

—

TSHASell

2026-01-12 · Taysha Gene Therapies, Inc.

$942.0K

—

TSHAExercise

2026-01-12 · Taysha Gene Therapies, Inc.

$151.6K

—

TSHAExercise

2026-01-12 · Taysha Gene Therapies, Inc.

$77.8K

—

TSHASell

2025-12-01 · Taysha Gene Therapies, Inc.

$1.17M

—

TSHAExercise

2025-12-01 · Taysha Gene Therapies, Inc.

$444.7K

—

TSHASell

2025-11-28 · Taysha Gene Therapies, Inc.

$523.1K

—

TSHAExercise

2025-11-28 · Taysha Gene Therapies, Inc.

$68.3K

—

TSHAExercise

2025-11-28 · Taysha Gene Therapies, Inc.

$49.0K

—

TSHASell

2025-09-10 · Taysha Gene Therapies, Inc.

$646.0K

—

TSHAExercise

2025-09-10 · Taysha Gene Therapies, Inc.

$28.8K

—

TSHASell

2025-08-21 · Taysha Gene Therapies, Inc.

$162.6K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.